Triple
T23186863
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | VelocImmune technology |
E579613
|
entity |
| Predicate | notableProductAssociation |
P1448
|
FINISHED |
| Object | REGN-COV2 antibody cocktail |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: REGN-COV2 antibody cocktail | Statement: [VelocImmune technology, notableProductAssociation, REGN-COV2 antibody cocktail]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: REGN-COV2 antibody cocktail Context triple: [VelocImmune technology, notableProductAssociation, REGN-COV2 antibody cocktail]
-
A.
REGN-COV2
chosen
REGN-COV2 is a monoclonal antibody cocktail designed to prevent and treat COVID-19 by targeting the SARS-CoV-2 virus.
-
B.
mRNA-1273
mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
-
C.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
D.
Sinopharm BIBP COVID-19 vaccine
The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine developed by the Beijing Institute of Biological Products and widely used globally, particularly in many low- and middle-income countries, to prevent COVID-19.
-
E.
Comirnaty
Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: notableProductAssociation Context triple: [VelocImmune technology, notableProductAssociation, REGN-COV2 antibody cocktail]
-
A.
notablyAssociatedWith
Indicates that one entity is prominently or distinctively connected with another in a way that is especially noteworthy or remarkable.
-
B.
notableProduct
chosen
Indicates that a product is especially significant, prominent, or well-known in relation to the associated entity.
-
C.
sharesNotableAssociationWith
Indicates a mutual, noteworthy connection or linkage between two entities that is significant enough to be recognized or highlighted.
-
D.
notoriouslyAssociatedWith
Indicates a widely recognized and often negative or infamous association between one entity and another.
-
E.
notableRelatedList
Indicates that there exists a curated or recognized list that is notably related to the subject, typically grouping it with similar or thematically connected entities.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e245ff8000819090d12008805315b7 |
completed | April 17, 2026, 2:38 p.m. |
| NER | Named-entity recognition | batch_69f18fd3aaa08190b9cf7afe4ee5a38d |
completed | April 29, 2026, 4:57 a.m. |
| PD | Predicate disambiguation | batch_69ef8a041c0081909afb670d17a5aaba |
completed | April 27, 2026, 4:08 p.m. |
Created at: April 17, 2026, 4:05 p.m.